🔍 📞 🔍
Main Menu
Sign into your HANYS account

- Remdesivir

An antiviral medication developed by Gilead Sciences, remdesivir was approved or authorized for emergency use to treat COVID‑19 in about 50 countries during the 2020 pandemic. However, updated guidelines from the World Health Organization in November 2020 include a conditional recommendation against the use of remdesivir for the treatment of COVID-19.